Drug Detail
Information about BBI503
Generic Name |
||
|---|---|---|
IND |
BBI503 | |
Brand Name (US) |
||
Manufacturer |
Boston Biomedical | |
Drug Type |
||
Delivery |
Oral | |
Approval Status |
Phase 1 | |
Indications |
||
Overall Strategy |
Oncogenic Signal Path Based | |
Strategy |
Inhibits Stem Cell survival | |
Drug Category |
Stem Cell inhibitor | |
Links |
|
Trials of this drug |
|
|
A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors |
Trial results |
|
Search for this drug/combination in: